Monday 30 November 2015

RFID in Healthcare Market Forecast, Industry Outlook, Market Demand, Share 2015 To 2022 by Grand View Research, Inc.



Global RFID in healthcare market is expected to reach USD 4,866 million by 2022, according to a new study by Grand View Research, Inc. Major factors facilitating its growth include increasing usage of RFID technologies pertaining to product & patient tracking and technological advancement such as the development of novel products which include Smart Face Technology & TexTrace RFID tag
Furthermore, improvements pertaining to efficiency of supply chain and inventory accuracy are expected to significantly drive the levels of RFID adoption in healthcare during the forecast period.
According to the data published by the National Institutes of Health in 2013, stated that each year nearly 98,000 deaths are caused in hospitals due to medical errors. Such escalating statistics has prompted the growth of RFID in healthcare market over the forecast period.
In addition, benefits pertaining to patient centric applications by embedding passive RFID into stationary devices and mobiles, has spurred the demand of RFID systems especially in point of care solutions, electronic medical records and automated pharmaceutical receipt & distribution.
Constant research activities undertaken by the nonprofit organizations such as the Health Industry Business Communications Council (HIBCC) to develop and promote the usage of advanced technological solutions such as multiresonator based chipless RFID tags, which in turn are expected to positively reinforce RFID in healthcare market growth over the forecast period.
RFID in healthcare industry is segmented on the basis of product type that includes RFID systems and tags. Further, systems and tags have been fragmented depending upon the use such as asset, pharmaceutical & patient tracking and blood monitoring. Due to rising concern for substantial inventory management of blood products, the blood monitoring systems are anticipated to gain momentum over the forecast period.
Further key findings from the study suggest:
  • In 2014, North America held largest market share of nearly 51% owing to the presence of sophisticated healthcare infrastructure, and increasing number of collaborations between medical device industry, regulatory authorities and nonprofit research organizations.
  • Furthermore, high level research expenditure pertaining to healthcare industry is anticipated to drive the RFID in healthcare market growth in the coming seven years.
  • Asia Pacific is expected to be one of the most lucrative regional market, growing at a CAGR of over 30% during the forecast period. Improving healthcare infrastructure and high level economic growth in developing countries such as China, India, and South Korea is expected to boost usage rates of RFID systems over the forecast period.
  • Furthermore, rising concern for patient safety and tracking of expensive medical devices, are among the key factors attributing to market growth in this region.
  • Key players operating in RFID in healthcare market include SpaceCode Technologies, Terso Solutions Inc., Dolphin RFID, GAO RFID, Smartrac NV, Motorola, CAEN RFID, Zebra and Alien technology. Constant implementation of innovative approaches in novel product development, are among the key strategies adopted by these major players.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the RFID in healthcare market on the basis of product, and region:
RFID in Healthcare Product Outlook (Revenue, USD Million, 2014 – 2022)
  • Systems
    • Asset Tracking Systems
    • Pharmaceutical Tracking Systems
    • Patient Tracking Systems
    • Blood Monitoring Systems
  • Tags
    • Asset Tracking Tags
    • Pharmaceutical Tracking Tags
    • Patient Tracking Tags
    • Blood Monitoring Tags
RFID in Healthcare Regional Outlook (Revenue, USD Million, 2014 – 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa 
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

3D Bioprinting Market Trends, Company Share To 2022: Grand View Research, Inc.



Global 3D bioprinting market is expected to reach USD 1.82 billion by 2022, according to a new report by Grand View Research Inc. Rising prevalence of chronic diseases such as Chronic Kidney Disease (CKD) which demands kidney transplantation is expected to boost the market growth, as 3D bioprinting is convenient and cost effective substitute for organ transplantation. 
Emerging medical applications of 3D bioprinting such as toxicity testing, drug discovery, tissue engineering and consumer product testing are expected to further drive the market growth positively. Increasing R&D expenditure is anticipated to be high impact rendering driver for the industry. 3D bioprinting advances in tissue engineering and allows developments to be done using biomaterials which have better biocompatibility. Moreover, rising geriatric population is expected to assist the market growth, as this demographic is highly susceptible to age related organ deformities.
Further key findings from the study suggest:
  • Syringe based printers dominated the technology segment as these printers allow working in sterile environment. Moreover, syringe based printers have wide applications which include fabrication of scaffolds, cell strips printing, and tissue printing.
  • Magnetic levitation based printers are expected to witness lucrative growth over the forecast period. This can be attributed to emerging medical applications such as screening of cardiovascular toxicity, human cell modeling and smooth muscle printing.
  • The medical applications segment is expected to gain substantial share of over 32.0% by 2022 which can be attributed to emerging applications of 3D bioprinting such as toxicity screening, organ transplants and medical pills.
  • Dental application segment is expected to witness lucrative growth over the forecast period. Rising demand for cosmetic dentistry along with growing awareness about oral hygiene are expected to foster the demand for dental applications.
  • North America dominated the regional 3D bioprinting market with over 35.0% share and is expected to grow at a CAGR of 10.0%. Supportive government initiatives to improve healthcare infrastructure coupled with growing disposable income are vital driving factor for this region’s growth.
  • Asia Pacific is expected to witness lucrative growth over the forecast period. Favorable government support to improve healthcare delivery with economic developments in emerging countries such as India and China are expected to increase the demand for 3D bioprinting.
  • Key players operating in the 3D bioprinting industry include Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel Group BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems, Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC, Bio3D Technologies, Solidscape and others.  
  • These players are involved in various strategic initiatives such as new product launches, strategic alliances and mergers and acquisitions to gain the edge over the competitors. For instance, In June 2015, Orgonovo collaborated with L’Oreal to develop skin tissue using NovoGen Bioprinting platform.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global 3D bioprinting market on the basis of products and region:
 3D Bioprinting Market Technology Outlook (USD million), 2012 – 2022
  • Magnetic levitation
  • Inkjet based
  • Syringe based
  • Laser based
  • Other
3D Bioprinting Market Application Outlook (USD million), 2012 – 2022
  • Medical
    • Tissue and organ generation
    • Medical pills
    • Prosthetics and implants
  • Dental
  • Biosensors
  • Consumer/Personal products testing
  • Bioinks
  • Food and animal product bioprinting
3D Bioprinting Market Regional Outlook (USD million), 2012 – 2022
  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Sunday 29 November 2015

Wound Dressings Market Research Report To 2022: Grand View Research, Inc.



The global wound dressings market is expected to reach USD 12.9 billion by 2022, according to a new report by Grand View Research Inc. Rising incidences of diseases such as leg ulcers that require thorough lesion management are expected to boost wound dressings market over the forecast period.
Additionally, the growing prevalence of lesion infection and burns globally is expected to foster growth of this industry. Rising geriatric population base boost demand by widening the patient base as people at this age are more susceptible towards diseases like lesions, foot ulcers, and diabetic foot.
Increasing incidences of sports injuries and the rising medical budgets by the sports centers, institutions and schools are expected to accentuate the industry’s growth over the coming seven years. Emergence of new technologies and their applications in products such as nanotechnology and electromagnetic therapy are expected to improvise lesion management thereby, boosting the overall wound dressings market.          
Further key findings from the report suggest:
  • Advanced wound products, which encompass moist, antimicrobial, and active products dominated the overall industry at over 56.1% of revenue share. This can be attributed to their high usage due to improved efficiency and cost-effectiveness.
  • Moist dressings was the largest advanced wound product segment in 2014 owing to the associated benefits such as creating & maintenance of wet environment around the injury, which assists in healing
  • On the other hand, the antimicrobial product segment, which consists silver and non-silver based products, is expected to exhibit fastest growth over the forecast period due to their benefits, which include easy usage and wide availability
  • North America dominated the overall wound dressings market in terms of revenue in 2014 at almost 35.1% majorly due to high awareness amongst people about personal hygiene coupled with high geriatric population base
  • The Asia Pacific wound dressings market is expected to grow at the fastest rate during the forecast period as a consequence of high unmet needs in this region coupled with improving healthcare infrastructure as a result of government initiatives
  • Key players of the wound dressings market include 3M Healthcare, ColoPlast, Medline Industries, HARTMANN, BSN Medical, Medtronic Plc, Smith & Nephew, ConvaTec, Derma Sciences, and Systagenix
  • Mergers & acquisitions and new product development are two key sustainability strategies adopted by these players
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/pharmaceuticals
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:
Subscribe to: Posts (Atom)